Costs of aspirin should include treatment costs for dyspepsia

May 2007    Volume 14, Issue 3   Br J Cardiol 2007;14:169-70

Authors:
Yohan P Samarasinghe, Ian Purcell, Helen Rivas-Toro, Michael D Feher

This short report describes a questionnaire study undertaken in two London teaching hospitals, addressing the true pharmacokinetic implications of aspirin use. It suggests that the real costs of aspirin treatment should include the cost of the therapies used for treatment of associated dyspepsia.

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top